VEGFC and neoplasm: In addition, the lymphangiogenic growth factor VEGF-C, secreted by tumor cells and transported in the extracellular matrix, appears to promote the expression and activation of α4β1 integrin on LECs, while the inhibition of α4β1 in LECs appears to significantly prevent lymphangiogenesis at the tumor periphery and the formation of lymph node metastases [47].